您的位置： 美股首页 > Zomedica Pharmaceuticals Corp股票行情 > Zomedica Pharmaceuticals Corp公司档案
- 美东时间：8月23日 01：50：15
- 北京时间：8月23日 01：50：15
- 东京时间：8月23日 01：50：15
- 伦敦时间：8月23日 01：50：15
| 今开： | 涨跌： | 最高： | 市值(亿美元)： |
| 昨收： | 涨跌幅： | 最低： | 市盈率： |
Zomedica Pharmaceuticals Corp公司介绍
| 证券代码： | ZOM | 上市板： | 主板 |
| 证券名称： | Zomedica Pharmaceuticals Corp | 上市场所： | 美国证券交易所 |
| 证券类型： | 普通股 | 发行方式： | 公开发售 |
| 首发上市日： | 首发价格(元)： | - | |
| 首发数量(股)： | - | 首发募资总额(USD/元)： | - |
Zomedica Pharmaceuticals Corp基本资料
| 公司名称： | Zomedica Pharmaceuticals Corp. | 注册地址： | 加拿大艾伯塔省 |
| 证券名称： | Zomedica Pharmaceuticals Corp | 上市场所： | 美国证券交易所 |
| 办公地址： | 3928 Varsity Drive, Ann Arbor, Michigan, USA | ||
| 董事会主席： | - | 成立日期： | 2013/01/07 |
| 公司属地： | Canada 加拿大 | 电话： | +1 (734) 369-2555 |
| 公司网址： | www.zomedica.com | ||
| 公司介绍： | Zomedica Pharmaceuticals Corp. is a development stage veterinary pharmaceuticals and health care solutions company focused on developing safe and effective treatments for companion animals, primarily dogs, cats, and horses. It seek to identify drugs for indications that has already demonstrated safety and efficacy in humans and to develop therapeutics based on these drugs for similar indications in companion animals. It believes that its development approach will enable it to reduce the risks associated with obtaining regulatory approval for unproven product candidates and shorten the development times to bring its product candidates to market. It has four drug product candidates in early development and have identified several other potential product candidates for further investigation. It believes that there are significant unmet medical needs for pets, and that the pet therapeutics and diagnostics segments of the animal health industry are likely to grow substantially as new treatments and diagnostic processes are identified, developed and marketed specifically for companion animals. |
||
